share_log

Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More

Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More

Psyched:迷幻药、作为突破性疗法的迷幻药、为伊博加因提供的1400万美元美联储拨款、印第安纳州的研究等等
Benzinga ·  03/20 14:49
FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement
FDA授予Cybin重度抑郁症突破性疗法地位,迷幻药疗法,公司公布积极的临床数据,加拿大1.5亿美元私募融资
Clinical-stage psychedelics biopharma company Cybin Inc. (NYSE:CYBN) announced that the Food and Drug Administration has granted Breakthrough Therapy designation to CYB003, its proprietary deuterated psilocybin analog targeting the adjunctive treatment of Major Depressive Disorder (MDD.)
临床阶段的迷幻药生物制药公司 Cybin Inc.(纽约证券交易所代码:CYBN)宣布,美国食品药品监督管理局已授予 CYB003 突破性疗法称号,这是其专有的针对重度抑郁症(MDD)辅助治疗的氘化迷幻药类似物。
It makes the group of psychedelic-based treatments for mental health conditions that have in recent years received such status granted by the U.S. federal agency five therapies total: Cybin's, MindMed's (NASDAQ:MNMD) LSD-derived treatment for Generalized Anxiety Disorder, MAPS...
它使近年来获得美国联邦机构授予此类地位的基于迷幻药的心理健康状况疗法共有五种疗法:Cyb...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发